Richardson Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
1,934
+530
+38% +$69.8K 0.14% 145
2026
Q1
$196K Sell
1,404
-16
-1% -$2.24K 0.12% 156
2025
Q4
$174K Sell
1,420
-50
-3% -$6.08K 0.06% 170
2025
Q3
$163K Sell
1,470
-40
-3% -$4.55K 0.1% 166
2025
Q2
$169K Buy
+1,510
New +$161K 0.11% 161
2024
Q1
Sell
-3,965
Closed -$321K 629
2023
Q4
$321K Buy
+3,965
New +$309K 0.28% 97

Other funds holding GILD

Richardson Financial Services's GILD Position: Q2 2026 in Review

Richardson Financial Services increased its Gilead Sciences (GILD) stake by 38% in Q2 2026, buying an estimated $69.8K and bringing the position to 1,934 shares worth $244K. The position accounts for 0.14% of the portfolio, ranked #145.

Richardson Financial Services first reported a position in GILD in Q4 2023 and has held it in 6 quarters since. The position peaked at $321K in Q4 2023. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Richardson Financial Services held 1,934 shares of Gilead Sciences worth $244K as of Q2 2026.
  • Richardson Financial Services bought 530 Gilead Sciences shares in Q2 2026, an estimated $69.8K.
  • Gilead Sciences made up 0.14% of Richardson Financial Services's portfolio in Q2 2026, its #145 holding.
  • Richardson Financial Services first reported a position in Gilead Sciences in Q4 2023 and has held it in 6 quarters since.
  • Richardson Financial Services's Gilead Sciences position peaked at $321K in Q4 2023.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.